Savara Inc. (SVRA): Wutah pendapatan triwulanan

Logo grafis savarapharma.com (SVRA)

The lack of alternatives upon drug approval will allow Savara Inc. (SVRA) to establish premium pricing. Quarterly revenue growth dynamics demonstrate current fluctuations, where 0.00 represents the current level of the metric. Growth prospects are tied to the approval of molgramostim for the treatment of PAP and acquisition potential. However, financial stability remains low due to the cash flow volatility characteristic of the clinical development stage.

Savara Inc (SVRA) - Wutah pendapatan kuartal marang kuartal saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Savara (SVRA)

- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian dhuwit lan gerakan dhuwit:
Analisis kabeh metrik perusahaan:Savara Inc. - SVRA
Produk seri savarapharma.com

For Savara Inc. (SVRA), the QoQ revenue growth rate reflects the efficiency of scaling sales for rare lung disease treatments following the completion of costly clinical trials. This indicator measures the percentage deviation of current revenues from the figures of the same quarter last year, allowing investors to assess expansion dynamics within a niche market and confirm the high margin profile of the assets.

Perusahaan pesaing

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|RIGL - Tingkat wutah pendapatan sajrone kuartal|AnaptysBio Inc. - Wutah dodolan triwulanan|Wutah pendapatan triwulanan Astria Therapeutics ATXS|ENGN: Wutah dodolan triwulanan|RAPT Therapeutics Inc. (RAPT) - Wutah dodolan triwulanan|JBIO (Aerovate Therapeutics) - Wutah dodolan triwulanan|ACRS: Owah-owahan dodolan kuartal marang kuartal|KYTX (Kyverna Therapeutics, Inc) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal TLSA (Tiziana Life Sciences PLC)|Wutah pendapatan triwulanan CABA|Wutah pendapatan kuartal marang kuartal VTYX (Ventyx Biosciences, Inc.)|Wutah pendapatan kuartal marang kuartal Theratechnologies Inc THTX|Tingkat wutah dodolan sajrone kuartal Avalo Therapeutics, Inc. (AVTX)|ELDN - Wutah pendapatan kuartal marang kuartal|AGEN - Wutah pendapatan triwulanan|climbbio.com (CLYM) - Wutah pendapatan kuartal marang kuartal|Zura Bio - Tambahing pendapatan triwulanan|ATYR (atyrpharma.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADAG (Adagene)|Wutah pendapatan triwulanan IMA|STTK (Shattuck Labs) - Tambahing pendapatan triwulanan|Equillium Inc - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan CNTB|IMUX - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATRA|IFRX (InflaRx) - Wutah dodolan triwulanan|X4 Pharma (XFOR) - Wutah pendapatan triwulanan|ACET (Adicet) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan celularity.com (CELU)|Wutah pendapatan kuartal marang kuartal INmune Bio Inc (INMB)|Tingkat wutah dodolan sajrone kuartal Barinthus Biotherapeutics PLC|Wutah pendapatan kuartal marang kuartal Kezar Life Sciences Inc KZR|Tambahing pendapatan triwulanan SABS|AKTX - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ENLV (enlivex.com)|QTTB: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal GOVX|Wutah dodolan triwulanan EDSA|Wutah dodolan kuartal marang kuartal IBIO (iBio Corp)|Wutah pendapatan kuartal marang kuartal Carisma Therapeutics Inc (CARM)|Tingkat wutah dodolan sajrone kuartal xtlbio.com|Bolt Biotherapeutics Inc. - Wutah dodolan triwulanan|HCW Biologics Inc (HCWB) - Tingkat wutah pendapatan sajrone kuartal|Aptevo - Wutah pendapatan triwulanan|AIM ImmunoTech (AIM) - Wutah dodolan triwulanan|Aditxt Corp (ADTX) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal GRI|Wutah dodolan triwulanan XRTX|Tingkat wutah pendapatan sajrone kuartal Vyome Holdings Inc. HIND|Wutah pendapatan triwulanan REVB|Tingkat wutah dodolan sajrone kuartal Indaptus Corp|BiondVax Pharmaceuticals - Wutah dodolan triwulanan|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan